Yuhan

Update in progress

000100.KS (KSE)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Yuhan Corporation is a Seoul-based pharmaceutical company serving Korea and international markets. It provides custom manufacturing, process research and development for APIs and intermediates, kilo- and pilot-scale production, commercial API/intermediate production, chemical specialties, and analytical method development with regulatory support. It supplies APIs/intermediates including antibiotics, anti-thrombotics, anti-hyperlipidemics, and anti-hypertensives, plus custom synthesis in antiviral, HIV, HCV, antibiotic, antihistamine, anti-diabetic, beta-lactamase inhibitor, CNS intermediates, PEG compounds, and more. Founded in 1926.

Company score

Sentiment: 0.77; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.47; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.57; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.24; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.38; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.57; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive